InvestorsHub Logo
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Re: n3m3sis post# 21542

Thursday, 09/07/2017 4:10:26 PM

Thursday, September 07, 2017 4:10:26 PM

Post# of 50157
N3, glad to see you here. This one is slightly higher risk than Cytrx in my opinion. However, it does have some similarities. They have interim trial results that is due second half of this year and we heard nothing of it yet. Some tutes holding shares but Aryton Captial sold 40 million where most believe they were in only to influence the vote outcome. Currently Hudson Bay, Ren, and Vanguard still holds a whole lot. So that's another similarity that some funds are betting on this.

I started following this since June pop on the no RS vote. 0.02 all time low to 0.36 is beyond amazing for those played it right. Even those those got in in the 15 - 20 chase still made some good profit.

The company is out of funding if RS do not pass because convertible debts depend on new shares and so they can get their remaining 13 million restricted cash.

The situation here is a bit more dire for management because they are out of funds. What this leads to are speculations of potential deal in the making. One due the trial results not being out yet when expected, and two no RS no money may force a deal through. At one people people were talking management has been rather quiet and don't release much news anymore.

I say this one is higher risk because management didn't openly say they are seeking strategic partnership and if one do happen it is likely done out of desperation rather than sound planning. So the results is a bit unpredictable. Plus no funding can result in potential BK filing however less likely that might be.

None the less we have very good trading opportunities here because the SP is so low even just a few pennies move is a good percentage of profit.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News